Search Results - Stanizzi, Darren

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    Trial in Progress: A First-in-Human Phase 1/2 Study of Hematopoietic Stem Cell Transplantation (HCT) with VOR33 (CD33-Deleted Allograft) Followed By Treatment with Gemtuzumab Ozogamicin (GO) in Patients with CD33+ Acute Myeloid Leukemia (AML) Who Are at High-Risk of Post-HCT Relapse

    Trial in Progress: A First-in-Human Phase 1/2 Study of Hematopoietic Stem Cell Transplantation (HCT) with VOR33 (CD33-Deleted Allograft) Followed By Treatment with Gemtuzumab Ozoga... by Cooper, Brenda W., Suh, Hyung C., Koura, Divya, Koehne, Guenther, Cho, Christina, Bambace, Nadia M., Bernard, Léa, Shah, Nirali N., Walter, Roland B., DiPersio, John F., Nath, Sritama, Lee-Sundlov, Melissa M., Lacy, Ali, Stanizzi, Darren, Kuhn, Karen, Whangbo, Jennifer S., Slapak, Christopher, Raffel, Glen D.

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: